呼吸

订阅

MedSci主页 / 所有栏目 / 呼吸

第24届世界肌肉协会年会：AT132治疗X连锁型肌管肌病的ASPIRO试验取得新阳性数据

2019-10-07 Allan MedSci原创

ASPIRO试验AT132X连锁型肌管肌病
关注

Audentes是一家领先的基于AAV的基因药物公司，致力于开发针对严重的罕见神经肌肉疾病的创新疗法，Audentes今天宣布了ASPIRO的新阳性数据，该临床试验评估了AT132治疗X连锁型肌管肌病（XLMTM）的有效性和安全性。数据由James J. Dowling博士在第24届世界肌肉协会年会上发表。

Audentes是一家领先的基于AAV的基因药物公司，致力于开发针对严重的罕见神经肌肉疾病的创新疗法，Audentes今天宣布了ASPIRO的新阳性数据，该临床试验评估了AT132治疗X连锁型肌管肌病（XLMTM）的有效性和安全性。数据由James J. Dowling博士在第24届世界肌肉协会年会上发表。

James J. Dowling博士说：“在两个剂量组中接受治疗的患者均显示出呼吸机依赖性的显著降低，这表明AT132有潜力为XLMTM患者和家庭带来变革性收益”。XLMTM是一种主要影响运动所用的肌肉（骨骼肌）的疾病，患者常骨骼脆弱，脊柱弯曲，自主呼吸困难，面部表情生硬，反射缺乏。


原始出处：

http://www.firstwordpharma.com/node/1671995#axzz61Rlned4y

本文系梅斯医学（MedSci）原创编译整理，转载需授权!


版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1665432, encodeId=5b141665432fb, content=<a href='/topic/show?id=f6fd1891e53' target=_blank style='color:#2F92EE;'>#X连锁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18917, encryptionId=f6fd1891e53, topicName=X连锁)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb025960146, createdName=12498ebem27暂无昵称, createdTime=Wed May 20 18:41:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069179, encodeId=6ecc20691e9a2, content=<a href='/topic/show?id=d6ad2885f1' target=_blank style='color:#2F92EE;'>#ASPIRO试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2885, encryptionId=d6ad2885f1, topicName=ASPIRO试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Wed Mar 11 08:41:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715752, encodeId=d4261e1575275, content=<a href='/topic/show?id=3b2918921c2' target=_blank style='color:#2F92EE;'>#X连锁型肌管肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18921, encryptionId=3b2918921c2, topicName=X连锁型肌管肌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa732030095, createdName=fengyqf, createdTime=Thu Apr 16 15:41:00 CST 2020, time=2020-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941467, encodeId=be9f194146e42, content=<a href='/topic/show?id=9d86291e2d' target=_blank style='color:#2F92EE;'>#AT132#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2917, encryptionId=9d86291e2d, topicName=AT132)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Mon May 25 13:41:00 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622412, encodeId=277d1622412f3, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Wed Oct 09 01:41:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373619, encodeId=d3e43e3619f8, content=向科研人员致敬！, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Mon Oct 07 11:49:06 CST 2019, time=2019-10-07, status=1, ipAttribution=)]
    2020-05-20 12498ebem27暂无昵称

    #X连锁#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1665432, encodeId=5b141665432fb, content=<a href='/topic/show?id=f6fd1891e53' target=_blank style='color:#2F92EE;'>#X连锁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18917, encryptionId=f6fd1891e53, topicName=X连锁)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb025960146, createdName=12498ebem27暂无昵称, createdTime=Wed May 20 18:41:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069179, encodeId=6ecc20691e9a2, content=<a href='/topic/show?id=d6ad2885f1' target=_blank style='color:#2F92EE;'>#ASPIRO试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2885, encryptionId=d6ad2885f1, topicName=ASPIRO试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Wed Mar 11 08:41:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715752, encodeId=d4261e1575275, content=<a href='/topic/show?id=3b2918921c2' target=_blank style='color:#2F92EE;'>#X连锁型肌管肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18921, encryptionId=3b2918921c2, topicName=X连锁型肌管肌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa732030095, createdName=fengyqf, createdTime=Thu Apr 16 15:41:00 CST 2020, time=2020-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941467, encodeId=be9f194146e42, content=<a href='/topic/show?id=9d86291e2d' target=_blank style='color:#2F92EE;'>#AT132#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2917, encryptionId=9d86291e2d, topicName=AT132)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Mon May 25 13:41:00 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622412, encodeId=277d1622412f3, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Wed Oct 09 01:41:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373619, encodeId=d3e43e3619f8, content=向科研人员致敬！, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Mon Oct 07 11:49:06 CST 2019, time=2019-10-07, status=1, ipAttribution=)]
    2020-03-11 drwjr

    #ASPIRO试验#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1665432, encodeId=5b141665432fb, content=<a href='/topic/show?id=f6fd1891e53' target=_blank style='color:#2F92EE;'>#X连锁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18917, encryptionId=f6fd1891e53, topicName=X连锁)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb025960146, createdName=12498ebem27暂无昵称, createdTime=Wed May 20 18:41:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069179, encodeId=6ecc20691e9a2, content=<a href='/topic/show?id=d6ad2885f1' target=_blank style='color:#2F92EE;'>#ASPIRO试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2885, encryptionId=d6ad2885f1, topicName=ASPIRO试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Wed Mar 11 08:41:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715752, encodeId=d4261e1575275, content=<a href='/topic/show?id=3b2918921c2' target=_blank style='color:#2F92EE;'>#X连锁型肌管肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18921, encryptionId=3b2918921c2, topicName=X连锁型肌管肌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa732030095, createdName=fengyqf, createdTime=Thu Apr 16 15:41:00 CST 2020, time=2020-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941467, encodeId=be9f194146e42, content=<a href='/topic/show?id=9d86291e2d' target=_blank style='color:#2F92EE;'>#AT132#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2917, encryptionId=9d86291e2d, topicName=AT132)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Mon May 25 13:41:00 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622412, encodeId=277d1622412f3, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Wed Oct 09 01:41:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373619, encodeId=d3e43e3619f8, content=向科研人员致敬！, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Mon Oct 07 11:49:06 CST 2019, time=2019-10-07, status=1, ipAttribution=)]
    2020-04-16 fengyqf

    #X连锁型肌管肌病#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1665432, encodeId=5b141665432fb, content=<a href='/topic/show?id=f6fd1891e53' target=_blank style='color:#2F92EE;'>#X连锁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18917, encryptionId=f6fd1891e53, topicName=X连锁)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb025960146, createdName=12498ebem27暂无昵称, createdTime=Wed May 20 18:41:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069179, encodeId=6ecc20691e9a2, content=<a href='/topic/show?id=d6ad2885f1' target=_blank style='color:#2F92EE;'>#ASPIRO试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2885, encryptionId=d6ad2885f1, topicName=ASPIRO试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Wed Mar 11 08:41:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715752, encodeId=d4261e1575275, content=<a href='/topic/show?id=3b2918921c2' target=_blank style='color:#2F92EE;'>#X连锁型肌管肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18921, encryptionId=3b2918921c2, topicName=X连锁型肌管肌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa732030095, createdName=fengyqf, createdTime=Thu Apr 16 15:41:00 CST 2020, time=2020-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941467, encodeId=be9f194146e42, content=<a href='/topic/show?id=9d86291e2d' target=_blank style='color:#2F92EE;'>#AT132#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2917, encryptionId=9d86291e2d, topicName=AT132)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Mon May 25 13:41:00 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622412, encodeId=277d1622412f3, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Wed Oct 09 01:41:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373619, encodeId=d3e43e3619f8, content=向科研人员致敬！, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Mon Oct 07 11:49:06 CST 2019, time=2019-10-07, status=1, ipAttribution=)]
    2020-05-25 xugumin

    #AT132#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1665432, encodeId=5b141665432fb, content=<a href='/topic/show?id=f6fd1891e53' target=_blank style='color:#2F92EE;'>#X连锁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18917, encryptionId=f6fd1891e53, topicName=X连锁)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb025960146, createdName=12498ebem27暂无昵称, createdTime=Wed May 20 18:41:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069179, encodeId=6ecc20691e9a2, content=<a href='/topic/show?id=d6ad2885f1' target=_blank style='color:#2F92EE;'>#ASPIRO试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2885, encryptionId=d6ad2885f1, topicName=ASPIRO试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Wed Mar 11 08:41:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715752, encodeId=d4261e1575275, content=<a href='/topic/show?id=3b2918921c2' target=_blank style='color:#2F92EE;'>#X连锁型肌管肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18921, encryptionId=3b2918921c2, topicName=X连锁型肌管肌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa732030095, createdName=fengyqf, createdTime=Thu Apr 16 15:41:00 CST 2020, time=2020-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941467, encodeId=be9f194146e42, content=<a href='/topic/show?id=9d86291e2d' target=_blank style='color:#2F92EE;'>#AT132#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2917, encryptionId=9d86291e2d, topicName=AT132)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Mon May 25 13:41:00 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622412, encodeId=277d1622412f3, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Wed Oct 09 01:41:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373619, encodeId=d3e43e3619f8, content=向科研人员致敬！, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Mon Oct 07 11:49:06 CST 2019, time=2019-10-07, status=1, ipAttribution=)]
    2019-10-09 爆笑小医

    #肌病#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1665432, encodeId=5b141665432fb, content=<a href='/topic/show?id=f6fd1891e53' target=_blank style='color:#2F92EE;'>#X连锁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18917, encryptionId=f6fd1891e53, topicName=X连锁)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb025960146, createdName=12498ebem27暂无昵称, createdTime=Wed May 20 18:41:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069179, encodeId=6ecc20691e9a2, content=<a href='/topic/show?id=d6ad2885f1' target=_blank style='color:#2F92EE;'>#ASPIRO试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2885, encryptionId=d6ad2885f1, topicName=ASPIRO试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Wed Mar 11 08:41:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715752, encodeId=d4261e1575275, content=<a href='/topic/show?id=3b2918921c2' target=_blank style='color:#2F92EE;'>#X连锁型肌管肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18921, encryptionId=3b2918921c2, topicName=X连锁型肌管肌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa732030095, createdName=fengyqf, createdTime=Thu Apr 16 15:41:00 CST 2020, time=2020-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941467, encodeId=be9f194146e42, content=<a href='/topic/show?id=9d86291e2d' target=_blank style='color:#2F92EE;'>#AT132#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2917, encryptionId=9d86291e2d, topicName=AT132)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Mon May 25 13:41:00 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622412, encodeId=277d1622412f3, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Wed Oct 09 01:41:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373619, encodeId=d3e43e3619f8, content=向科研人员致敬！, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Mon Oct 07 11:49:06 CST 2019, time=2019-10-07, status=1, ipAttribution=)]
    2019-10-07 坚强007

    向科研人员致敬！

    0